CancerSymptoms.org
  Home | Ask an Oncology Nurse | Glossary Award winning site maintained by the Oncology Nursing Society    
CancerSymptoms.org
Learn Manage
References
  1. Andersson, K. E., Appell, R., Cardozo, L. D. Chapple, C., Drutz, H., Finkbeiner, A. E. Haab, F, & Navarrete, R. V. (1999). The pharmacological treatment of urinary incontinence. British Journal of Urology, 84, 923-947.
  2. Ayton, R. A., Darling G. M., Murkies, A. L., Farrell, E. A. , Weisberg, E., Selinus, I. & Fraser, I . S. (1996). A comparative study of safety and efficacy of continuous low dose oestradiol released from a vaginal ring compared with conjugated equine oestrogen vaginal cream in the threatment of postmenopausal urogenital atrophy. British Journal of Obstetrics and Gynecology, 103, 351-358.
  3. Barensten, R., van de Weijer, P. H. M. & Schram, J. H. N. (1997). Continuous low dose estradiol released from a vaginal ring versus estriol vaginal cream for urogenital atrophy. European Journal of Obstetrics & Gynecology and Reproductive Biology, 71, 73-80.
  4. Barrett-Connor, E. & Goodman-Gruen, D. (1999). Cognitive function and endogenous sex hormones in older women. The Journal of the American Geriatrics Society, 47, 1289-1293.
  5. Barton, D., LaVasseur, B., Loprinzi, C., Novotny, P., Wilwerding, M. B. & Sloan J. (2002). Venlafaxine for the control of hot flashes: Results of a longitudinal continuation study. Oncology Nursing Forum, 29, 33-40.
  6. Barton, D. L, & Loprinzi, C. L. (2002). Novel approaches to preventing chemotherapy-induced cognitive dysfunction: the art of the possible. Clinical Breast Cancer, 3, S121-S127.
  7. Barton, D. & Loprinzi, C. L. (2004). Making sense of the evidence regarding nonhormonal treatments for hot flashes. Clinical Journal of Oncology Nursing, 8, 39-41.
  8. Barton, D. L., Loprinzi, C. L. & Gostout, B. (2002). Current management of menopausal symptoms in cancer patients. Oncology, 16, 67-74.
  9. Barton, D. L., Loprinzi, C. L., & Ko, M. G. (2002). Managing hot flashes: findings on alternatives to traditional hormonal therapy. Menopause Management, 11, 15-19.
  10. Barton, D.L., Loprinzi, C. L., Novotny, P., Shanafelt, T., Sloan, J., Dakhill, S., Martin, L., Wahner-Roedler, D., Rummans, T., & Christensen, B. (2003). Pilot evaluation of citalopram for the relief of hot flashes. The Journal of Supportive Oncology, 1, 47-52.
  11. Barton, D.L., Loprinzi, C. L., Quella, S., Sloan, J., Veeder, M., Egner, J., Fidler, P., Stella P., Swan, D., Vaught, N., & Novotny, P. (1998). Prospective evaluation of vitamin E for hot flashes in breast cancer survivors. Journal of Clinical Oncology 16, 495-500.
  12. Barton., D., Wilwerding, MB., Carpenter, L., & Loprinzi, C. (2004). Libido as part of sexuality in female cancer survivors. ONF, 31, 599-607.
  13. Bilezikian, J. P. (2002). Bisphosphonates: New dosing regimens and approaches to treatment. Menopause Management, 11, 20-25.
  14. Burghardt, M. (1999). Exercise at menopause: a critical difference. Oncology, 14, 1- 11.
  15. Burgio, K. L., Locher, J. L., Goode, P. S., Hardin, J. M., McDowell, B. J., Dombrowski, M. & Candib, D. (1998). Behavioral vs. drug treatment for urge urinary incontinence in older women: a randomized controlled trial. Journal of the American Medical Association, 280, 1995-2000.
  16. Bygdeman, M. & Swahn, M. L. (1996). Replens versus dienoestrol cream in the symptomatic treatment of vaginal atrophy in postmenopausal women. Maturitas, 23, 259-263.
  17. Cheater, F. M. A. (1996). Promoting urinary continence. Nursing Standard, 10, 47-54.
  18. Delmas, P. D., Balena, R., Confravreux, E., Hardouin, C., Hardy, P. & Bremond, A. (1997). Bisphosphonate risedronate prevents bone loss in women with articificial menopause due to chemotherapy: A double-blind, placebo-controlled study. Journal of Clinical Oncology, 15, 955-962.
  19. Espeland, M. A., Rapp, S. R., Shumaker, S. A., Brunner, R., Manson, J. E., Sherwin, B. B., Hsia, J., Margolis, K. L., Hogen, P. E., Wallace, R., Dailey, M., Freeman, R., & Hays, J. for the Women's Health Initiative Memory Study. Conjugated equine estrogens and global cognitive function in postmenopausal women: women's health initiative memory study. JAMA, 291, 2959-2968.
  20. Freedman, R. & Woodward, S. (1992). Behavioral treatment of menopausal hot flushes: evaluation by ambulatory monitoring. American Journal of Obstetrics and Gynecology, 167, 436-439.
  21. Ganz, P.A., Desmond, K.A., Leedham, B., Rowland, J.H., Meyerowitz, B. E., & Belin, T. R. (2002). Quality of life in long-term, disease-free survivors: Results of a randomized trial. Journal of the National Cancer Institute, 92, 1054-1064.
  22. Garrison, R.., & Somer, E. (1995). The Nutrition Desk Reference. 3rd edition. New Canaan, CT: Keats Publishing. (p. 50).
  23. Gleason, D. M., Susset, J., White, C., Munoz, D. R. & Sand, P.K. (1999). Evaluation of a new once-daily formulation of oxybutynin for the treatment of urinary urge incontinence. Urology, 54, 420-423.
  24. Gooren, LJG & Bunck, CM. (2004). Androgen replacement therapy present and future. Drugs, 64, 1861-1891.
  25. Griffiths, C. E. M. (1999). Drug treatment of photoaged skin. Drugs and Aging, 14, 289-301.
  26. Handa, V. L., Bachus, K. E., Johnston, M. W., Robboy, S. J., & Hammond, C. B. (1994). Vaginal administration of low-dose conjugated estrogens: systemic absorption and effects on the endometrium. Obstetrics and Gynecology, 84, 215-218.
  27. Hartman, L. C., & Loprinzi, C. L. (2005). Mayo Clinic Guide to Women's Cancers. Rochester, MN: Mayo Clinic Health Information. (p. 559).
  28. Holzbeierlein, J.M., Castle, E., & Thrasher, J.B. (2004). Complications of androgen deprivation therapy: Prevention and treatment. Oncology, 18, 303-309.
  29. Holzbeierlein, JM, McLaughlin, MD & Thrasher, JB. (2004). Complications of androgen depriviation therapy for prostate cancer. Current Opinions in Urology, 14, 177-183.
  30. HOPE and HOPE-TOO trial investigators (2005). Effect of Long-term Vitamin E supplementation on cardiovascular events and cancer. A Randomized controlled trial. JAMA, 293,1338-1347.
  31. Irvin, J.H., Domar, A. D., Clark, C., Zuttermeister, P. C., & Freedman, R. (1996). The effects of relaxation response training on menopausal symptoms. Journal of psychosomatic obstetrics and gynecology, 17, 202-207.
  32. Ivarsson, T., Spetz, A. C. & Hammar, M. Physical exercise and vasomotor symptoms in postmenopausal women. Maturitas, 29 397-422.
  33. Jacobsen, J. S., Troxel, A. B., Evans, J., Klaus, L., Vahdat, L., Kinne, D., SteveLo, K. M., Moore, A., Rosenman, P.J., Kaufman, E. L., Neugut, A. & Grann, V. R. (2001). Randomized trial of black cohosh for the treatment of hot flashes among women with a history of breast cancer. Journal of Clinical Oncoloyg, 19, 2739-2745.
  34. Jones, C., & Czajkowski, L. (2002). Evaluation and management of insomnia in menopause. Clinical Obstetrics and Gynecology, 43, 184-197.
  35. Kampen, D. L. & Sherwin, B. B. (1994). Estrogen use and verbal memory in healthy postemenopausal women. Obstetrics and gynecology, 83, 979-983.
  36. Kushi, L. H., Fee, R. M., Folsom, A. R. et al (1997). Physical activity and mortality in postmenopausal women. JAMA, 277, 1287-1292.
  37. Lackner, T. E. (2000). Pharmacologic management of urinary incontinence. Annals of Long Term Care, 8, 29-37.
  38. Laumann, E.O., Paik, A., & Rosen, R.C. (1999). Sexual dysfunction in the United States: Prevalence and predictors. JAMA, 281, 537-544.
  39. Liu, J., Burdette, J.E., Xu, H., Gu, C., van Breemen, R.B., Bhat, K. P. L.l, Booth, N., Constantinou, A. I., Pezzuto, J. M., Fong, H. H. S., Farnsworth, N. R. & Bolton, J. L. (2001). Evaluation of estrogenic activity of plant extracts for the potential treatment of menopausal symptoms. Journal of Agricultural Food Chemistry, 49, 2472-2479.
  40. Loprinzi, C. L., Abu-Ghazaleh, S., Sloan, J. A., vanHaelst-Pisani, C., Hammer, A. M., Rowland, K. M., Law, M., Windschitly, H. E., Kaur, J. S. & Ellison, N. (1997). Phase III randomized double-blind study to evaluate the efficacy of a polycarbophil-based vaginal moisturizer in women with breast cancer. Journal of Clinical Oncology, 15, 969-973.
  41. Loprinzi, C. L., Barton, D. L., Sloan, J. A., Zahasky, K. M., Smith, D. A., Pruthi, S., et al. (2002). Pilot evaluation of gabapentin for treating hot flashes. Mayo Clinic Proceedings, 77, 1159-1163.
  42. Manonai, J., Theppisai, W., Suthutvorabut, S., Udomsubpayakul, U. & Chittacharoen, A. (2001). The effect of estradiol vaginal tablet and conjugated estrogen cream on urogenital symptoms in postmenopausal women: a comparative study. Journal of Obstetrical and Gynecological Research, 27, 255-260.
  43. Mathijssen, R. H. J., Verweij, J., deBruijn, P., Loos, W. J. & Sparreboom, A. (2002). Effects of St. John's Wort on irinotecan metabolism. Journal of the National Cancer Institute, 94, 1247-1249.
  44. McKenna, D. J., Jones, K., Humphrey, S., & Hughes, K. (2001). Black Cohosh: efficacy, safety and use in clinical and preclinical applications. Alternative Therapies, 7, 93-100.
  45. Morin, C. M., Culbert, J. P. & Schwartz, S. M. (1994). Nonpharmacological interventions for insomnia: A meta-analysis of treatment efficacy. American Journal of Psychiatry, 151, 1172-1180.
  46. nccam.nih.gov/health/supplement-safety/ Accessed December, 2004.
  47. North American Menopause Society. (2002). Management of postmenopausal osteoporosis: position statement of the North American Menopause Society. Menopause, 9, 84-101.
  48. Pate, R. R., Pratt, M., Blair, S. N. et al. (1995). Physical activity and public health: A recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine. JAMA, 273, 402-407.
  49. Pinkerton, J. V. & Santen, R. (1999). Alternatives to the use of estrogen in postmenopausal women. Endocrine Reviews, 20, 308-320.
  50. Pockaj BA, Gallagher, J., Loprinzi, CL, Stella PJ, Barton DL, Sloan JA, Rao, R., Fitch, T., Rowland, K., & Novotny, P. (2005). "Phase III double blinded randomized trial to evaluate the use of black cohosh in the treatment of hot flashes: A NCCTG study", Journal Clinical Oncology, 23(16S), 732s, #8013.
  51. Pockaj, B., Loprinzi, C., Sloan, J., Novotny, P., Barton D., Hagenmaier, A., Zhang, H., Lambert, G., Reeser, K. & Wisbey, J. (2004). Pilot evaluation of black cohosh for the treatment of hot flashes in women. Cancer Investigation, 22, 515-521.
  52. Rako, S. (2000). Testosterone supplemental therapy after hysterectomy with or without concomitant oopherectomy. Estrogen alone is not enough. Journal of Women's Health and Gender-based Medicine, 9, 917-923.
  53. Shumaker, S.A., Legault, C., Kuller, L., Rapp, S. R., Thal, L., Lane, D. S., Fillit, H., Stefanick, M. L., Hendrix, S., Lewis, C. E. Masaki, K., Coker, L. H. (2004). Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: women's health initiative memory study. JAMA, 291, 2947-2958.
  54. Shumaker, S. A., Legault, C. & Rapp, S. R. (2003). Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women. The women's health initiative memory study: a randomized controlled trial. JAMA, 289, 2651-2662.
  55. Simpkins, L. H. (1999). Taking care of your skin as you age. Lippincotts Primary Care Practice, 3, 179-181.
  56. Smith, MR. (2004). Changes in fat and lean body mass during androgen-deprivation therapy for prostate cancer. Urology, 63, 742-745.
  57. Smith, MR. (2004). Osteoporosis and obesity in men receiving hormone therapy for prostate cancer. The Journal of Urology, 172, S52-S57.
  58. Speight, J.L., Elkin, E. P., Pasta D. J., Silva, S., Lubeck, D.P., Carroll, P. R. & Litwin, M. S. (2004). Longitudinal assessment of changes in sexual function and bother in patients treated with external beam radiotherapy or brachytherapy, with and without neoadjuvant androgen ablation: data from CaPSURE. International Journal of Radiation Oncology, Biology and Physics, 15, 1066-1075.
  59. Stearns, V., Johnson, M.D., Rae, J.M., Morocho, A., Noviella, A., Bhargava, P., Hayes, D.F., Desta, Z. & Flockhart, D. A. (2003). Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and selective serotonin reuptake inhibitor paroxetine. Journal of the National Cancer Institute, 95, 16-22.
  60. Sullivan, J. & Abrams, P. (1999). Pharmacological management of incontinence. European Urology, 36s, 89-95.
  61. "Urinary tract infections" accessed at www.4women.gov/faq/uti.htm, December, 2004.
  62. Varani, J., Warner, R. L., Gharaee-Kermani, M., Phan, S. H., Kang, S., Chung, J., Wang, Z., Datta, S. C., Fisher, G.J. & Voorhees, J. J. (2000). Vitamin A anatagonizes decreased cell growth and elevated collagen-degrading matrix metalloproteinases and stimulates collagen accumulation in naturally aged human skin. The Journal of Investigative Dermatology, 114, 480-486.
  63. Wijma, K., Melin, A., Nedstrand, E. & Hammar, M. (1997). Treatment of menopausal symptoms with applied relaxation: A pilot study. Journal of Behavioral Therapy and Experimental Psychiatry. 28, 251-261.
  64. Willhite, L. A. & O'Connell, M. B. (2001). Urogenital Atrophy: prevention and treatment. Pharmacotherapy, 21, 464-480.
  
Contributors | Contact ONS | Terms of Use | Privacy | © 2006 Oncology Nursing Society